Clinical Trials List
2018-06-08 - 2021-01-31
Phase II
Terminated6
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/03/01
Investigators and Locations
Co-Principal Investigator
- KUO-HSUAN HSU Division of Thoracic Medicine
- TSUNG -YING YANG Division of Thoracic Medicine
- 陳焜結 Division of Thoracic Medicine
- YEN-HSIANG HUANG Division of Thoracic Medicine
- JENG-SEN TSENG Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chao-Hua Chiu Division of Hematology & Oncology
- 楊朝能 Division of Thoracic Medicine
- Hsu-ching Huang Division of Hematology & Oncology
- 蕭慈慧 Division of Thoracic Medicine
- 趙恒勝 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chih-Liang Wang Division of Hematology & Oncology
- Ping-Chih Hsu Division of Hematology & Oncology
- 黃振洋 Division of Hematology & Oncology
- Shih-Hong Li Division of Hematology & Oncology
- Wen-Cheng Chang Division of Hematology & Oncology
- Chien-Ying Liu Division of Hematology & Oncology
- 柯皓文 Division of Hematology & Oncology
- Chih-Hung Chen Division of Hematology & Oncology
- 枋岳甫 Division of Hematology & Oncology
- Chih-Hsi Kuo Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Tzu-Tao Chen Division of Thoracic Medicine
- YEN-HAN TSENG Division of Thoracic Medicine
- Ching-Shan Luo Division of Thoracic Medicine
- Po-Hao Feng Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Shang-Yin Wu Division of General Internal Medicine
- Chien-Chung Lin Division of General Internal Medicine
- Wen-Pin Su Division of General Internal Medicine
- Wei-Pang Chung Division of General Internal Medicine
- Yu-Min Yeh Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- 吳尚俊 Division of General Internal Medicine
- Chia-Chi Lin Division of Hematology & Oncology
- 陳冠宇 Division of General Internal Medicine
- 廖斌志 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- JIN-YUAN SHIH Division of General Internal Medicine
- 蔡子修 Division of General Internal Medicine
- Chong-Jen Yu Division of General Internal Medicine
- 林宗哲 Division of Hematology & Oncology
- 許嘉林 Division of General Internal Medicine
- 廖唯昱 Division of General Internal Medicine
- CHAO-CHI HO CHAO-CHI HO Division of General Internal Medicine
- 林育麟 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 楊景堯 Division of General Internal Medicine
The Actual Total Number of Participants Enrolled
0 Terminated
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
24 participants
-
Global
120 participants
